MedTrace Logo

Wearable Sensor for Early Detection and Monitoring of Cognitive Decline

NCT07780162 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-08-21

No results posted yet for this study

Summary

This observational study will enroll approximately 100 participants evenly split by cognitive status (Cognitively Impaired vs Non-Cognitively Impaired), and involves four clinic visits over one year (at baseline, 3, 6, and 12 months), each followed by 7 days of remote monitoring to assess the long-term feasibility of PAMSys+ (Physical Activity Monitoring System).

Conditions

  • Mild Cognitive Impairment (MCI)
  • Older Adults With Cognitive Decline
  • Older Adults

Sponsors & Collaborators

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-15
Primary Completion
2029-12-31
Completion
2030-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07780162 on ClinicalTrials.gov